Zsz
2021-03-26
Do comment!
5 of Thursday’s 6 IPOs Fall Below Offer Prices<blockquote>周四 6 笔 IPO 中有 5 笔跌破发行价</blockquote>
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
5
2
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":358482747,"tweetId":"358482747","gmtCreate":1616722796889,"gmtModify":1634524364435,"author":{"id":3577162823356617,"idStr":"3577162823356617","authorId":3577162823356617,"authorIdStr":"3577162823356617","name":"Zsz","avatar":"https://static.tigerbbs.com/71f20502a5ac8aec5b0d547f909943cc","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":8,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>Do comment!</p></body></html>","htmlText":"<html><head></head><body><p>Do comment!</p></body></html>","text":"Do comment!","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":5,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/358482747","repostId":1122505368,"repostType":4,"repost":{"id":"1122505368","kind":"news","pubTimestamp":1616722520,"share":"https://www.laohunote.com/m/news/1122505368?lang=zh_CN&edition=full","pubTime":"2021-03-26 09:35","market":"us","language":"en","title":"5 of Thursday’s 6 IPOs Fall Below Offer Prices<blockquote>周四 6 笔 IPO 中有 5 笔跌破发行价</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1122505368","media":"barrons","summary":"Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the","content":"<p>Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the initial public offering.</p><p><blockquote>周四有六家公司在股市首次亮相,但只有一家——Olink Holding——的收盘价高于首次公开募股。</blockquote></p><p> Shares of Olink (ticker: OLK), a Swedish proteomics company, kicked off at $30.10 and peaked at $38.99. The stock ended Thursday up $16, or 80%, at $36.</p><p><blockquote>瑞典蛋白质组学公司 Olink(股票代码:OLK)的股价开盘价为 30.10 美元,最高价为 38.99 美元。该股周四收盘上涨 16 美元,涨幅 80%,至 36 美元。</blockquote></p><p> Jay Ritter, a University of Florida professor who studies IPOs, said that Thursday wasn’t a bad day for the market even though five of the six stock sales broke, or fell below their offering prices. Instead, he said, IPOs are being priced closer to the actual value of the stock.</p><p><blockquote>佛罗里达大学(University of Florida)研究首次公开募股(IPO)的教授杰伊-里特(Jay Ritter)说,尽管六笔股票发售中有五笔破产或跌破发行价,但周四对市场来说并不是糟糕的一天。相反,他说,IPO 的定价更接近股票的实际价值。</blockquote></p><p> Since April 1 last year, he said, the average first day gain for IPOs was 38%, Ritter said. “The average first day return this month was down to 10%, including today’s deals,” Ritter told<i>Barron’s</i>.</p><p><blockquote>里特说,自去年 4 月 1 日以来,IPO 的平均首日涨幅为 38%。“里特说:”包括今天的交易在内,本月的平均首日回报率降至 10%。<i>巴伦</i>.</blockquote></p><p> Olink raised nearly $353 million,selling 17,647,058 shares at $20 each, comfortably above the range of $16 to $18 it had told investors to expect. All the other five priced their shares at or below the forecasted prices,Goldman,Morgan Stanley,and SVB Leerink are underwriters on the deal.</p><p><blockquote>Olink 筹集了近 3.53 亿美元,以每股 20 美元的价格出售了 17,647,058 股股票,远高于其告诉投资者预期的 16 至 18 美元的范围。所有其他五家公司的股价均达到或低于预测价格,高盛、摩根士丹利和 SVB Leerink 是该交易的承销商。</blockquote></p><p> Olink, based in Sweden, provides products and services for proteomics research. It reported $6.78 million in losses on $54 million in revenue for 2020,according to its prospectus.</p><p><blockquote>总部位于瑞典的Olink为蛋白质组学研究提供产品和服务。根据其招股说明书,该公司报告 2020 年收入为 5400 万美元,亏损 678 万美元。</blockquote></p><p> Vizio Holding (VZIO), a provider of smart TVs, meanwhile, dropped below its $21 IPO price. The stock started off at $17.50, hit a high of $19.49, and closed at $19.10, off more than 9%.</p><p><blockquote>与此同时,智能电视供应商 Vizio Holding (VZIO) 的 IPO 价格跌破 21 美元。该股开盘价为17.50美元,最高触及19.49美元,收盘价为19.10美元,跌幅超过9%。</blockquote></p><p> Vizio’s tepid performance came after the company cut the size of its deal by nearly 19%,selling 12,250,000 shares at $21 each. It had planned to offer 15.12 million shares at between $21 and $23. J.P. Morgan and BofA Securities are underwriters on the deal.</p><p><blockquote>Vizio 业绩不温不火之前,该公司将交易规模削减了近 19%,以每股 21 美元的价格出售了 1225 万股股票。该公司原计划以 21 至 23 美元的价格发行 1512 万股股票。摩根大通和美国银行证券是该交易的承销商。</blockquote></p><p> Vizio has sold 82.2 million televisions and 11.8 million sound bars since its founding in 2002,its prospectus said. The Irving, Calif.-based company is profitable, reporting $102.5 million in earnings on $2 billion in revenue for 2020.</p><p><blockquote>Vizio 的招股说明书称,自 2002 年成立以来,已售出 8220 万台电视机和 1180 万个条形音箱。这家总部位于加利福尼亚州欧文市的公司实现了盈利,2020 年收入为 20 亿美元,盈利为 1.025 亿美元。</blockquote></p><p> Vizio will be using proceeds from the IPO to invest in people and technology, Adam Townsend, Vizio’s CFO, told<i>Barrons</i>from the NYSE before trading began.</p><p><blockquote>Vizio 首席财务官 Adam Townsend 表示,Vizio 将利用 IPO 的收益投资于人才和技术。<i>巴伦</i>交易开始前来自纽约证券交易所。</blockquote></p><p> When asked about growth, Townsend pointed to the company’s SmartCast platform, which lets users stream programs from services such as Hulu,NetflixandAmazonPrime on the TVs. The SmartCast platform had 12.2 million active accounts at the end of 2020, the prospectus said. SmartCast is becoming an “increasingly bigger part of [Vizio’s) business in terms of revenue growth and profit contribution,” he said.</p><p><blockquote>当被问及增长情况时,汤森提到了该公司的 SmartCast 平台,该平台允许用户在电视上观看 Hulu、Netflix 和 AmazonPrime 等服务的节目。招股书称,截至2020年底,SmartCast平台拥有1220万个活跃账户。他说,“就收入增长和利润贡献而言,SmartCast 正在成为 [Vizio] 业务中越来越大的一部分”。</blockquote></p><p> Cricut (CRCT) also dropped during its debut Thursday. The stock opened at $15.80, peaked at $18.45, and closed at $17.80, down 11%.</p><p><blockquote>Cricut (CRCT) 也在周四的首次亮相中下跌。该股开盘价为15.80美元,最高价为18.45美元,收盘价为17.80美元,下跌11%。</blockquote></p><p> Cricut raised $306.2 million late Wednesday afterselling about 15.3 million shares at $20 each, the bottom of its $20-to-$22 price range.Goldman Sachsand Morgan Stanley are underwriters on the deal.</p><p><blockquote>Cricut 周三晚间筹集了 3.062 亿美元,以每股 20 美元的价格出售了约 1530 万股股票,这是其 20 至 22 美元价格区间的底部。高盛和摩根士丹利是该交易的承销商。</blockquote></p><p> Cricut provides computer-controlled cutting machines that are designed for home crafters or hobbyists. The machines, which sell for between $179.99 to $399.99, help users cut different materials, like paper, vinyl, leather, for craft projects. Cricut also offers accessories like mats and craft tools.</p><p><blockquote>Cricut提供专为家庭工匠或业余爱好者设计的计算机控制切割机。这些机器的售价在179.99美元到399.99美元之间,可以帮助用户切割不同的材料,如纸张、乙烯基、皮革,用于工艺项目。Cricut还提供垫子和工艺工具等配件。</blockquote></p><p> Cricut is profitable: It reported $154.5 million in income on $959 million in total revenue for 2020, itsprospectus said.</p><p><blockquote>Cricut 是盈利的:其招股说明书称,2020 年总收入为 9.59 亿美元,收入为 1.545 亿美元。</blockquote></p><p> Shares of SEMrush (SEMR) opened at $11.50, off nearly 18% from its $14 IPO price. The stock hit a high of $12.14 and closed Thursday at $11.22, off nearly 20%.</p><p><blockquote>SEMrush (SEMR) 的股价开盘价为 11.50 美元,较 14 美元的 IPO 价格下跌近 18%。该股触及12.14美元的高点,周四收于11.22美元,下跌近20%。</blockquote></p><p> Late Wednesday, SEMrush slashed the size of its offering by 40%,selling 10 million shares at $14 each. It had planned to offer 16.8 million shares at $14 to $16 each. Goldman Sachs, J.P. Morgan, Jefferies, and KeyBanc Capital Markets are underwriters on the deal.</p><p><blockquote>周三晚间,SEMrush 将发行规模削减了 40%,以每股 14 美元的价格出售 1000 万股股票。该公司原计划以每股 14 至 16 美元的价格发行 1680 万股股票。高盛、摩根大通、杰富瑞和 KeyBanc Capital Markets 是该交易的承销商。</blockquote></p><p> SEMrush provides a software-as-a-service platform that helps companies reach the correct audience for their content, using the appropriate channels and in the right context, its prospectus said. The company isn’t profitable<b>,</b>posting $7 million in losses on $124.9 million in revenue for 2020, theprospectus said.</p><p><blockquote>SEMrush 的招股说明书称,SEMrush 提供了一个软件即服务平台,帮助公司使用适当的渠道和在正确的背景下,为其内容接触到正确的受众。公司没有盈利<b>,</b>招股书称,2020 年收入为 1.249 亿美元,亏损 700 万美元。</blockquote></p><p> Diversey Holdings(DSEY) delivered the biggest deal, but its shares didn’t trade above their $15 IPO price. Diversey’s stock opened at $13.50 and closed at their high of $14.98, off 2 cents.</p><p><blockquote>Diversey Holdings(DSEY)完成了最大的一笔交易,但其股价并未超过 15 美元的 IPO 价格。Diversey 的股票开盘价为 13.50 美元,收盘价最高为 14.98 美元,下跌 2 美分。</blockquote></p><p> Diversey collected $692.3 million afterselling 46,153,846 at $15 each, below its $18-to-$21 price range.Citigroup,Morgan Stanley,Barclays,and J.P. Morgan are underwriters on the deal.</p><p><blockquote>Diversey 以每股 15 美元的价格售出 46,153,846 股,筹集了 6.923 亿美元,低于其 18 至 21 美元的价格范围。花旗集团、摩根士丹利、巴克莱和摩根大通是该交易的承销商。</blockquote></p><p> Diversey provides cleaning chemicals, equipment, and services to customers in the food and beverage, healthcare, and building services industries. The company reported $183.3 million in losses on $2.6 billion in sales for 2020,a prospectus said. Its long-term debt totaled $2.7 billion in 2020.</p><p><blockquote>Diversey为食品和饮料、医疗保健和建筑服务行业的客户提供清洁化学品、设备和服务。招股说明书称,该公司报告 2020 年销售额为 26 亿美元,亏损 1.833 亿美元。2020年,其长期债务总额为27亿美元。</blockquote></p><p> Sealed Air(SEE)sold the Diversey businessto Bain Capital in 2017 for about $3.2 billion. Bain will own nearly 76% of the company after the IPO.</p><p><blockquote>Sealed Air (SEE) 于 2017 年以约 32 亿美元的价格将 Diversey 业务出售给贝恩资本。IPO后,贝恩将拥有该公司近76%的股份。</blockquote></p><p></p><p> Lastly, LAVA Therapeutics (LVTX) also dropped below its $15 IPO price. Shares opened at $12, peaked at $15.29 and ended down 4.7% at $14.30.</p><p><blockquote>最后,LAVA Therapeutics (LVTX) 也跌破了 15 美元的 IPO 价格。股价开盘价为 12 美元,最高价为 15.29 美元,收盘下跌 4.7%,至 14.30 美元。</blockquote></p><p> The company collected $100.5 million afterselling 6.7 million shares at $15 each, in the middle of its $14-to-$16 price range. J.P. Morgan, Jefferies, and SVB Leerink were underwriters on the deal.</p><p><blockquote>该公司以每股 15 美元的价格出售 670 万股股票,在 14 至 16 美元的价格区间中间,筹集了 1.005 亿美元。摩根大通、杰富瑞和 SVB Leerink 是该交易的承销商。</blockquote></p><p> LAVA, a biotech, is developing therapies to treat tumor cell cancers. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of hematologic cancers. The company reported $13.9 million in losses on $3.2 million in revenue in 2020,a prospectus said. It had 31 employees.</p><p><blockquote>生物技术公司LAVA正在开发治疗肿瘤细胞癌的疗法。其主要候选产品LAVA-051正在推进治疗血液癌症的1/2a期临床试验。招股说明书称,该公司报告 2020 年收入为 320 万美元,亏损 1390 万美元。它有31名员工。</blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 of Thursday’s 6 IPOs Fall Below Offer Prices<blockquote>周四 6 笔 IPO 中有 5 笔跌破发行价</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 of Thursday’s 6 IPOs Fall Below Offer Prices<blockquote>周四 6 笔 IPO 中有 5 笔跌破发行价</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">barrons</strong><span class=\"h-time small\">2021-03-26 09:35</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the initial public offering.</p><p><blockquote>周四有六家公司在股市首次亮相,但只有一家——Olink Holding——的收盘价高于首次公开募股。</blockquote></p><p> Shares of Olink (ticker: OLK), a Swedish proteomics company, kicked off at $30.10 and peaked at $38.99. The stock ended Thursday up $16, or 80%, at $36.</p><p><blockquote>瑞典蛋白质组学公司 Olink(股票代码:OLK)的股价开盘价为 30.10 美元,最高价为 38.99 美元。该股周四收盘上涨 16 美元,涨幅 80%,至 36 美元。</blockquote></p><p> Jay Ritter, a University of Florida professor who studies IPOs, said that Thursday wasn’t a bad day for the market even though five of the six stock sales broke, or fell below their offering prices. Instead, he said, IPOs are being priced closer to the actual value of the stock.</p><p><blockquote>佛罗里达大学(University of Florida)研究首次公开募股(IPO)的教授杰伊-里特(Jay Ritter)说,尽管六笔股票发售中有五笔破产或跌破发行价,但周四对市场来说并不是糟糕的一天。相反,他说,IPO 的定价更接近股票的实际价值。</blockquote></p><p> Since April 1 last year, he said, the average first day gain for IPOs was 38%, Ritter said. “The average first day return this month was down to 10%, including today’s deals,” Ritter told<i>Barron’s</i>.</p><p><blockquote>里特说,自去年 4 月 1 日以来,IPO 的平均首日涨幅为 38%。“里特说:”包括今天的交易在内,本月的平均首日回报率降至 10%。<i>巴伦</i>.</blockquote></p><p> Olink raised nearly $353 million,selling 17,647,058 shares at $20 each, comfortably above the range of $16 to $18 it had told investors to expect. All the other five priced their shares at or below the forecasted prices,Goldman,Morgan Stanley,and SVB Leerink are underwriters on the deal.</p><p><blockquote>Olink 筹集了近 3.53 亿美元,以每股 20 美元的价格出售了 17,647,058 股股票,远高于其告诉投资者预期的 16 至 18 美元的范围。所有其他五家公司的股价均达到或低于预测价格,高盛、摩根士丹利和 SVB Leerink 是该交易的承销商。</blockquote></p><p> Olink, based in Sweden, provides products and services for proteomics research. It reported $6.78 million in losses on $54 million in revenue for 2020,according to its prospectus.</p><p><blockquote>总部位于瑞典的Olink为蛋白质组学研究提供产品和服务。根据其招股说明书,该公司报告 2020 年收入为 5400 万美元,亏损 678 万美元。</blockquote></p><p> Vizio Holding (VZIO), a provider of smart TVs, meanwhile, dropped below its $21 IPO price. The stock started off at $17.50, hit a high of $19.49, and closed at $19.10, off more than 9%.</p><p><blockquote>与此同时,智能电视供应商 Vizio Holding (VZIO) 的 IPO 价格跌破 21 美元。该股开盘价为17.50美元,最高触及19.49美元,收盘价为19.10美元,跌幅超过9%。</blockquote></p><p> Vizio’s tepid performance came after the company cut the size of its deal by nearly 19%,selling 12,250,000 shares at $21 each. It had planned to offer 15.12 million shares at between $21 and $23. J.P. Morgan and BofA Securities are underwriters on the deal.</p><p><blockquote>Vizio 业绩不温不火之前,该公司将交易规模削减了近 19%,以每股 21 美元的价格出售了 1225 万股股票。该公司原计划以 21 至 23 美元的价格发行 1512 万股股票。摩根大通和美国银行证券是该交易的承销商。</blockquote></p><p> Vizio has sold 82.2 million televisions and 11.8 million sound bars since its founding in 2002,its prospectus said. The Irving, Calif.-based company is profitable, reporting $102.5 million in earnings on $2 billion in revenue for 2020.</p><p><blockquote>Vizio 的招股说明书称,自 2002 年成立以来,已售出 8220 万台电视机和 1180 万个条形音箱。这家总部位于加利福尼亚州欧文市的公司实现了盈利,2020 年收入为 20 亿美元,盈利为 1.025 亿美元。</blockquote></p><p> Vizio will be using proceeds from the IPO to invest in people and technology, Adam Townsend, Vizio’s CFO, told<i>Barrons</i>from the NYSE before trading began.</p><p><blockquote>Vizio 首席财务官 Adam Townsend 表示,Vizio 将利用 IPO 的收益投资于人才和技术。<i>巴伦</i>交易开始前来自纽约证券交易所。</blockquote></p><p> When asked about growth, Townsend pointed to the company’s SmartCast platform, which lets users stream programs from services such as Hulu,NetflixandAmazonPrime on the TVs. The SmartCast platform had 12.2 million active accounts at the end of 2020, the prospectus said. SmartCast is becoming an “increasingly bigger part of [Vizio’s) business in terms of revenue growth and profit contribution,” he said.</p><p><blockquote>当被问及增长情况时,汤森提到了该公司的 SmartCast 平台,该平台允许用户在电视上观看 Hulu、Netflix 和 AmazonPrime 等服务的节目。招股书称,截至2020年底,SmartCast平台拥有1220万个活跃账户。他说,“就收入增长和利润贡献而言,SmartCast 正在成为 [Vizio] 业务中越来越大的一部分”。</blockquote></p><p> Cricut (CRCT) also dropped during its debut Thursday. The stock opened at $15.80, peaked at $18.45, and closed at $17.80, down 11%.</p><p><blockquote>Cricut (CRCT) 也在周四的首次亮相中下跌。该股开盘价为15.80美元,最高价为18.45美元,收盘价为17.80美元,下跌11%。</blockquote></p><p> Cricut raised $306.2 million late Wednesday afterselling about 15.3 million shares at $20 each, the bottom of its $20-to-$22 price range.Goldman Sachsand Morgan Stanley are underwriters on the deal.</p><p><blockquote>Cricut 周三晚间筹集了 3.062 亿美元,以每股 20 美元的价格出售了约 1530 万股股票,这是其 20 至 22 美元价格区间的底部。高盛和摩根士丹利是该交易的承销商。</blockquote></p><p> Cricut provides computer-controlled cutting machines that are designed for home crafters or hobbyists. The machines, which sell for between $179.99 to $399.99, help users cut different materials, like paper, vinyl, leather, for craft projects. Cricut also offers accessories like mats and craft tools.</p><p><blockquote>Cricut提供专为家庭工匠或业余爱好者设计的计算机控制切割机。这些机器的售价在179.99美元到399.99美元之间,可以帮助用户切割不同的材料,如纸张、乙烯基、皮革,用于工艺项目。Cricut还提供垫子和工艺工具等配件。</blockquote></p><p> Cricut is profitable: It reported $154.5 million in income on $959 million in total revenue for 2020, itsprospectus said.</p><p><blockquote>Cricut 是盈利的:其招股说明书称,2020 年总收入为 9.59 亿美元,收入为 1.545 亿美元。</blockquote></p><p> Shares of SEMrush (SEMR) opened at $11.50, off nearly 18% from its $14 IPO price. The stock hit a high of $12.14 and closed Thursday at $11.22, off nearly 20%.</p><p><blockquote>SEMrush (SEMR) 的股价开盘价为 11.50 美元,较 14 美元的 IPO 价格下跌近 18%。该股触及12.14美元的高点,周四收于11.22美元,下跌近20%。</blockquote></p><p> Late Wednesday, SEMrush slashed the size of its offering by 40%,selling 10 million shares at $14 each. It had planned to offer 16.8 million shares at $14 to $16 each. Goldman Sachs, J.P. Morgan, Jefferies, and KeyBanc Capital Markets are underwriters on the deal.</p><p><blockquote>周三晚间,SEMrush 将发行规模削减了 40%,以每股 14 美元的价格出售 1000 万股股票。该公司原计划以每股 14 至 16 美元的价格发行 1680 万股股票。高盛、摩根大通、杰富瑞和 KeyBanc Capital Markets 是该交易的承销商。</blockquote></p><p> SEMrush provides a software-as-a-service platform that helps companies reach the correct audience for their content, using the appropriate channels and in the right context, its prospectus said. The company isn’t profitable<b>,</b>posting $7 million in losses on $124.9 million in revenue for 2020, theprospectus said.</p><p><blockquote>SEMrush 的招股说明书称,SEMrush 提供了一个软件即服务平台,帮助公司使用适当的渠道和在正确的背景下,为其内容接触到正确的受众。公司没有盈利<b>,</b>招股书称,2020 年收入为 1.249 亿美元,亏损 700 万美元。</blockquote></p><p> Diversey Holdings(DSEY) delivered the biggest deal, but its shares didn’t trade above their $15 IPO price. Diversey’s stock opened at $13.50 and closed at their high of $14.98, off 2 cents.</p><p><blockquote>Diversey Holdings(DSEY)完成了最大的一笔交易,但其股价并未超过 15 美元的 IPO 价格。Diversey 的股票开盘价为 13.50 美元,收盘价最高为 14.98 美元,下跌 2 美分。</blockquote></p><p> Diversey collected $692.3 million afterselling 46,153,846 at $15 each, below its $18-to-$21 price range.Citigroup,Morgan Stanley,Barclays,and J.P. Morgan are underwriters on the deal.</p><p><blockquote>Diversey 以每股 15 美元的价格售出 46,153,846 股,筹集了 6.923 亿美元,低于其 18 至 21 美元的价格范围。花旗集团、摩根士丹利、巴克莱和摩根大通是该交易的承销商。</blockquote></p><p> Diversey provides cleaning chemicals, equipment, and services to customers in the food and beverage, healthcare, and building services industries. The company reported $183.3 million in losses on $2.6 billion in sales for 2020,a prospectus said. Its long-term debt totaled $2.7 billion in 2020.</p><p><blockquote>Diversey为食品和饮料、医疗保健和建筑服务行业的客户提供清洁化学品、设备和服务。招股说明书称,该公司报告 2020 年销售额为 26 亿美元,亏损 1.833 亿美元。2020年,其长期债务总额为27亿美元。</blockquote></p><p> Sealed Air(SEE)sold the Diversey businessto Bain Capital in 2017 for about $3.2 billion. Bain will own nearly 76% of the company after the IPO.</p><p><blockquote>Sealed Air (SEE) 于 2017 年以约 32 亿美元的价格将 Diversey 业务出售给贝恩资本。IPO后,贝恩将拥有该公司近76%的股份。</blockquote></p><p></p><p> Lastly, LAVA Therapeutics (LVTX) also dropped below its $15 IPO price. Shares opened at $12, peaked at $15.29 and ended down 4.7% at $14.30.</p><p><blockquote>最后,LAVA Therapeutics (LVTX) 也跌破了 15 美元的 IPO 价格。股价开盘价为 12 美元,最高价为 15.29 美元,收盘下跌 4.7%,至 14.30 美元。</blockquote></p><p> The company collected $100.5 million afterselling 6.7 million shares at $15 each, in the middle of its $14-to-$16 price range. J.P. Morgan, Jefferies, and SVB Leerink were underwriters on the deal.</p><p><blockquote>该公司以每股 15 美元的价格出售 670 万股股票,在 14 至 16 美元的价格区间中间,筹集了 1.005 亿美元。摩根大通、杰富瑞和 SVB Leerink 是该交易的承销商。</blockquote></p><p> LAVA, a biotech, is developing therapies to treat tumor cell cancers. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of hematologic cancers. The company reported $13.9 million in losses on $3.2 million in revenue in 2020,a prospectus said. It had 31 employees.</p><p><blockquote>生物技术公司LAVA正在开发治疗肿瘤细胞癌的疗法。其主要候选产品LAVA-051正在推进治疗血液癌症的1/2a期临床试验。招股说明书称,该公司报告 2020 年收入为 320 万美元,亏损 1390 万美元。它有31名员工。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.barrons.com/articles/6-companies-are-making-their-trading-debuts-thursday-51616692763?mod=hp_LEAD_4\">barrons</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.barrons.com/articles/6-companies-are-making-their-trading-debuts-thursday-51616692763?mod=hp_LEAD_4","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122505368","content_text":"Six companies made their stock-market debuts on Thursday, but only one—Olink Holding—ended above the initial public offering.\nShares of Olink (ticker: OLK), a Swedish proteomics company, kicked off at $30.10 and peaked at $38.99. The stock ended Thursday up $16, or 80%, at $36.\nJay Ritter, a University of Florida professor who studies IPOs, said that Thursday wasn’t a bad day for the market even though five of the six stock sales broke, or fell below their offering prices. Instead, he said, IPOs are being priced closer to the actual value of the stock.\nSince April 1 last year, he said, the average first day gain for IPOs was 38%, Ritter said. “The average first day return this month was down to 10%, including today’s deals,” Ritter toldBarron’s.\nOlink raised nearly $353 million,selling 17,647,058 shares at $20 each, comfortably above the range of $16 to $18 it had told investors to expect. All the other five priced their shares at or below the forecasted prices,Goldman,Morgan Stanley,and SVB Leerink are underwriters on the deal.\nOlink, based in Sweden, provides products and services for proteomics research. It reported $6.78 million in losses on $54 million in revenue for 2020,according to its prospectus.\nVizio Holding (VZIO), a provider of smart TVs, meanwhile, dropped below its $21 IPO price. The stock started off at $17.50, hit a high of $19.49, and closed at $19.10, off more than 9%.\nVizio’s tepid performance came after the company cut the size of its deal by nearly 19%,selling 12,250,000 shares at $21 each. It had planned to offer 15.12 million shares at between $21 and $23. J.P. Morgan and BofA Securities are underwriters on the deal.\nVizio has sold 82.2 million televisions and 11.8 million sound bars since its founding in 2002,its prospectus said. The Irving, Calif.-based company is profitable, reporting $102.5 million in earnings on $2 billion in revenue for 2020.\nVizio will be using proceeds from the IPO to invest in people and technology, Adam Townsend, Vizio’s CFO, toldBarronsfrom the NYSE before trading began.\nWhen asked about growth, Townsend pointed to the company’s SmartCast platform, which lets users stream programs from services such as Hulu,NetflixandAmazonPrime on the TVs. The SmartCast platform had 12.2 million active accounts at the end of 2020, the prospectus said. SmartCast is becoming an “increasingly bigger part of [Vizio’s) business in terms of revenue growth and profit contribution,” he said.\nCricut (CRCT) also dropped during its debut Thursday. The stock opened at $15.80, peaked at $18.45, and closed at $17.80, down 11%.\nCricut raised $306.2 million late Wednesday afterselling about 15.3 million shares at $20 each, the bottom of its $20-to-$22 price range.Goldman Sachsand Morgan Stanley are underwriters on the deal.\nCricut provides computer-controlled cutting machines that are designed for home crafters or hobbyists. The machines, which sell for between $179.99 to $399.99, help users cut different materials, like paper, vinyl, leather, for craft projects. Cricut also offers accessories like mats and craft tools.\nCricut is profitable: It reported $154.5 million in income on $959 million in total revenue for 2020, itsprospectus said.\nShares of SEMrush (SEMR) opened at $11.50, off nearly 18% from its $14 IPO price. The stock hit a high of $12.14 and closed Thursday at $11.22, off nearly 20%.\nLate Wednesday, SEMrush slashed the size of its offering by 40%,selling 10 million shares at $14 each. It had planned to offer 16.8 million shares at $14 to $16 each. Goldman Sachs, J.P. Morgan, Jefferies, and KeyBanc Capital Markets are underwriters on the deal.\nSEMrush provides a software-as-a-service platform that helps companies reach the correct audience for their content, using the appropriate channels and in the right context, its prospectus said. The company isn’t profitable,posting $7 million in losses on $124.9 million in revenue for 2020, theprospectus said.\nDiversey Holdings(DSEY) delivered the biggest deal, but its shares didn’t trade above their $15 IPO price. Diversey’s stock opened at $13.50 and closed at their high of $14.98, off 2 cents.\nDiversey collected $692.3 million afterselling 46,153,846 at $15 each, below its $18-to-$21 price range.Citigroup,Morgan Stanley,Barclays,and J.P. Morgan are underwriters on the deal.\nDiversey provides cleaning chemicals, equipment, and services to customers in the food and beverage, healthcare, and building services industries. The company reported $183.3 million in losses on $2.6 billion in sales for 2020,a prospectus said. Its long-term debt totaled $2.7 billion in 2020.\nSealed Air(SEE)sold the Diversey businessto Bain Capital in 2017 for about $3.2 billion. Bain will own nearly 76% of the company after the IPO.\nLastly, LAVA Therapeutics (LVTX) also dropped below its $15 IPO price. Shares opened at $12, peaked at $15.29 and ended down 4.7% at $14.30.\nThe company collected $100.5 million afterselling 6.7 million shares at $15 each, in the middle of its $14-to-$16 price range. J.P. Morgan, Jefferies, and SVB Leerink were underwriters on the deal.\nLAVA, a biotech, is developing therapies to treat tumor cell cancers. Its lead product candidate, LAVA-051, is advancing toward a Phase 1/2a clinical trial for the treatment of hematologic cancers. The company reported $13.9 million in losses on $3.2 million in revenue in 2020,a prospectus said. It had 31 employees.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":529,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/358482747"}
精彩评论